ATE81782T1 - Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins. - Google Patents

Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins.

Info

Publication number
ATE81782T1
ATE81782T1 AT87400877T AT87400877T ATE81782T1 AT E81782 T1 ATE81782 T1 AT E81782T1 AT 87400877 T AT87400877 T AT 87400877T AT 87400877 T AT87400877 T AT 87400877T AT E81782 T1 ATE81782 T1 AT E81782T1
Authority
AT
Austria
Prior art keywords
purification
antigens
azellular
proteic
vaccine
Prior art date
Application number
AT87400877T
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Francois Arminjon
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Application granted granted Critical
Publication of ATE81782T1 publication Critical patent/ATE81782T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT87400877T 1986-04-16 1987-04-16 Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins. ATE81782T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8605456A FR2597344B1 (fr) 1986-04-16 1986-04-16 Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
EP87400877A EP0242301B1 (de) 1986-04-16 1987-04-16 Reinigungsverfahren der proteischen Antigene von Bordetella-Bakterien zur Gewinnung eines azellularen Vakzins

Publications (1)

Publication Number Publication Date
ATE81782T1 true ATE81782T1 (de) 1992-11-15

Family

ID=9334300

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87400877T ATE81782T1 (de) 1986-04-16 1987-04-16 Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins.

Country Status (12)

Country Link
US (1) US4774086A (de)
EP (1) EP0242301B1 (de)
JP (3) JP2563797B2 (de)
AT (1) ATE81782T1 (de)
AU (1) AU601415B2 (de)
CA (1) CA1328070C (de)
DE (3) DE242301T1 (de)
ES (1) ES2000435T3 (de)
FR (1) FR2597344B1 (de)
GR (2) GR880300043T1 (de)
LU (1) LU90378I2 (de)
ZA (1) ZA872712B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
US5032398A (en) * 1986-08-01 1991-07-16 Kaslow Harvey R Selective modification of the catalytic subunit of pertussis toxin
US5165927A (en) * 1986-08-01 1992-11-24 University Of Southern California Composition with modified pertussis toxin
US4845036A (en) * 1987-02-03 1989-07-04 The United States Of America As Represented By The Department Of Health And Human Services Process for isolation of the B oligomer of pertussis toxin
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
KR102426041B1 (ko) * 2017-08-01 2022-07-29 주식회사 녹십자 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) * 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4500639A (en) * 1981-10-15 1985-02-19 Teijin Limited Culturing Bordetella in media containing etherified cyclodextrin
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Lpf−haの精製法
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin
JPS60237027A (ja) * 1984-05-07 1985-11-25 Chemo Sero Therapeut Res Inst 線維状赤血球凝集素の精製方法
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine

Also Published As

Publication number Publication date
CA1328070C (fr) 1994-03-29
US4774086A (en) 1988-09-27
DE3782356T2 (de) 1993-04-29
JP2599260B2 (ja) 1997-04-09
JP2563797B2 (ja) 1996-12-18
JPH08225463A (ja) 1996-09-03
FR2597344B1 (fr) 1989-06-23
JP2599259B2 (ja) 1997-04-09
AU7158187A (en) 1987-10-22
GR880300043T1 (en) 1988-10-18
LU90378I2 (fr) 1999-05-31
JPH08231421A (ja) 1996-09-10
GR3006840T3 (de) 1993-06-30
JPS62258326A (ja) 1987-11-10
EP0242301A1 (de) 1987-10-21
DE242301T1 (de) 1988-06-09
ES2000435T3 (es) 1994-02-01
ES2000435A4 (es) 1988-03-01
ZA872712B (en) 1987-10-05
DE19875021I2 (de) 2010-07-01
EP0242301B1 (de) 1992-10-28
FR2597344A1 (fr) 1987-10-23
DE3782356D1 (de) 1992-12-03
AU601415B2 (en) 1990-09-13

Similar Documents

Publication Publication Date Title
DK512686A (da) Thrombinpraeparater, deres fremstilling og anvendelse
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE127345T1 (de) Stressproteine und verwendungen dafür.
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
ATE81782T1 (de) Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins.
GB9814538D0 (en) Helicobacter pylori bacterioferritin
DE3785157D1 (de) Verfahren zur herstellung von toxoid.
ATE422900T1 (de) Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält
DE3786708D1 (de) Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form.
EP0090660A3 (de) Neisseria Gonorrhöe Vakzin
ATE420951T1 (de) Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
ATE201448T1 (de) Impfstoffe auf der basis von streptokinase
ATE108664T1 (de) Verfahren zur verhütung von gvhd.
ATE88217T1 (de) Verfahren zur herstellung von difluorbenzamid.
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
ATE87658T1 (de) Verfahren zur selektiven biokonversion von isosorbid-dinitrat.
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions